Fig. 9From: Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancerAnalysis of immune checkpoint molecule expression levels. A–E Differences in expression of five immune checkpoint molecules, TIGIT, CTLA4, PD1, PD-L1, and LAG3, between low- and high-risk groupsBack to article page